Reduction of the concentrations of prostaglandins E 2 and F 2 , and thromboxane B 2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate

By Lai K.L.   Glauert H.P.  

Toxicology Letters, Vol. 85, Iss. 3, 1996-06 ,pp. : 143-149

Elsevier

Access to resources Recommend Favorite

Identification of a Novel Peroxisome Proliferator Responsive cDNA Isolated from Rat Hepatocytes as the Zinc-Finger Protein ZFP-37

By Vanden Heuvel J.P.   Holden P.   Tugwood J.   Ingle C.   Yen W.   Galjart N.   Greenlee W.F.  

Toxicology and Applied Pharmacology, Vol. 152, Iss. 1, 1998-09 ,pp. : 107-118

Elsevier

Access to resources Recommend Favorite

Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats

By Leung L.K.   Glauert H.P.  

Toxicology, Vol. 123, Iss. 1, 1997-11 ,pp. : 101-109

Elsevier

Access to resources Recommend Favorite

Effect of Rodent Hepatocarcinogenic Peroxisome Proliferators on Fatty Acyl-CoA Oxidase, DNA Synthesis, and Apoptosis in Cultured Human and Rat Hepatocytes

By Perrone C.E.   Shao L.   Williams G.M.  

Toxicology and Applied Pharmacology, Vol. 150, Iss. 2, 1998-06 ,pp. : 277-286

Elsevier

Access to resources Recommend Favorite

Effect of Peroxisome Proliferator Nafenopin on the Cytotoxicity of Dihaloalkanes in Isolated Rat Hepatocytes

By Voskoboinik I.   Drew R.   Ahokas J.T.  

Toxicology in Vitro, Vol. 10, Iss. 5, 1996-10 ,pp. : 577-584

Elsevier

Access to resources Recommend Favorite